Cost-of-living chasm buoying tech firms
A growing number of tech workers are seeking refuge in Indianapolis from skyrocketing living expenses in other cities, including technology hubs on the coasts.
A growing number of tech workers are seeking refuge in Indianapolis from skyrocketing living expenses in other cities, including technology hubs on the coasts.
Former Eli Lilly and Co. Nick LeRoy will lead the state board, which reviews, approves and regulates some of the state’s charter schools.
Roche could enjoy a huge increase in sales of its HPV tests if all doctors and women followed a recommendation issued last week by an advisory committee at the FDA. But wrinkles in the U.S. health care system still present several big obstacles.
Richard DiMarchi is being honored for his work on Eli Lilly and Co.'s Humalog, which has been used by millions around the world to address the complications of diabetes.
While life sciences companies don’t rack up huge jobs numbers, their relatively high pay means that every job they create is worth two in the rest of the private sector.
Technology and work habits are prompting firms to squish space allotted to workers.
Fritz French and Richard DiMarchi have raised $1.7 million from venture capitalists to launch Calibrium LLC, a biotech company that will develop diabetes drugs. French and DiMarchi were leaders of Marcadia Biotech Inc., which developed diabetes drugs based on DiMarchi's research as a chemistry professor at Indiana University. They sold the company for $287 million to Switzerland-based Roche in late 2010. In November, Calibrium struck a deal with Indiana University to fund 10 researchers in DiMarchi’s chemistry lab in Bloomington. Then in December, Calibrium secured convertible debt investments from two of the venture capital firms that backed Marcadia—San Francisco-based 5AM Ventures and Seattle-based Frazier Healthcare. Calibrium has hired Kristin Sherman as its chief financial officer; she held the same position at Marcadia. French said he expects more members of the Marcadia team to join Calibrium as its work advances.
Nearly two-thirds of the state’s nursing homes are now participating in partnerships with county-owned hospitals that effectively double their profit margins. The partnerships allow both hospitals and nursing homes to draw down extra federal money, which appears to give nursing homes at least 2 percent on top of their average profit margin of 2 percent. According to data from the Indiana State Department of Health, 329 nursing homes have sold their licenses to county-owned hospitals—63 percent of all nursing homes in the state and nearly 70 percent of those that offer beds to Medicaid patients. The partnerships with county-owned hospitals trigger larger payments from the federal agency that oversees the Medicare and Medicaid programs. Those payments average $71.54 per day for each Medicaid patient, according to analysis of Indiana data by the accounting firm Myers and Stauffer LC. It is unclear exactly how the hositals and nursing homes split that money, which totaled $313 million statewide last year. But Indiana Health Care Association officials said hospitals are paying nursing homes management fees that net out to about 2 percent of the nursing homes’ net patient revenue.
Hall Render Killian Heath & Lyman, the nation's largest health-care-focused law firm, ranked eighth on The Hill newspaper's 2013 top 10 list of Washington, D.C., lobbying firms based on the number of new client registrations. Last year, Indianapolis-based Hall Render registered 28 new clients. The firm created its federal legislative and regulatory advisory practice in 2012. The practice includes attorneys John Williams and John Render, as well as Andrew Coats, the son of Indiana Sen. Dan Coats.
Fritz French and Richard DiMarchi, the former leaders of Marcadia Biotech, have teamed up to launch the diabetes drug development firm Calibrium LLC.
U.S. sales are plunging for Roche Diagnostics Corp. and its fellow makers of diabetes-care devices because of lower reimbursements from the federal Medicare program. In five years, two of the four largest companies will have sold or closed their diabetes businesses, according to two industry analysts.
Reinforced coffee-table legs might be required if you are giving these impressive Indiana-focused books
Eli Lilly and Co., Pfizer Inc., Sanofi and other large drugmakers will keep paying doctors to give talks about their products, leaving GlaxoSmithKline Plc alone for now in its decision to halt such compensation.
The U.S. Environmental Protection Agency said it has invalidated renewable fuel credits sold by an Indiana company for biofuel it didn’t produce. The filing Wednesday follows fraud charges filed against the former owners of the Middletown-based E-Biofuels LLC in September.
Since 1998, there have been more than 100 attempts to develop an Alzheimer’s treatment, and all have failed. Such a product may generate as much as $5 billion annually for Merck, according to analysts
Indianapolis’ and Carmel’s work forces were so lacking in high-tech jobs in 2001 that the void led to breakneck-speed hiring over the past 12 years as the cities caught up—faster than almost any other place in the United States.
Head-trauma lawsuits by ex-football players filed against the NCAA defy easy consolidation—unlike National Football League cases consolidated by federal judges and later settled for $765 million.
Indianapolis Vex Robotics Competition is designed to buttress science, technology, engineering and math skills.
State Auditor Dwayne Sawyer—former president of the Brownsburg Town Council and the first black Republican to serve in a statewide office—said he was stepping down due to “family and personal concerns.”
An Indianapolis firm that makes software for libraries has teamed with an elementary schoolteacher to improve kids’ reading skills by using books’ longtime nemesis—video games.
The proposed Indiana Biosciences Research Institute, backed by Eli Lilly, Roche Diagnostics and other life sciences companies, now has $50 million in start-up funds and has started recruiting a CEO.